logo

Esperion Therapeutics (ESPR)



Trade ESPR now with
  Date
  Headline
11/1/2021 7:25:49 AM Esperion Appoints Seth Fischer To Board Of Directors
1/13/2021 6:30:25 AM Esperion Sees Q4 Preliminary Net U.S. Product Sales To Be Between $8.0 Mln And $8.5 Mln
11/7/2017 3:36:17 PM Jefferies Is Increasing Esperion Therapeutics (ESPR) FY18 Estimate To -8.54 From -9.36
11/7/2017 3:35:58 PM Jefferies Is Increasing Esperion Therapeutics (ESPR) FY17 Estimate To -7.43 From -7.45
2/23/2017 6:51:29 AM RBC Capital Markets Is Cutting Esperion Therapeutics (ESPR) 2018 Estimate To -6.29 From -4.72
2/23/2017 6:51:13 AM RBC Capital Markets Is Cutting Esperion Therapeutics (ESPR) 2017 Estimate To -5.87 From -4.52
2/23/2017 6:50:57 AM RBC Capital Markets Is Cutting Esperion Therapeutics (ESPR) 2016 Estimate To -3.33 From -2.85
2/23/2017 6:50:40 AM RBC Capital Markets Is Cutting Esperion Therapeutics (ESPR) Q4 17 Estimate To -1.60 From -1.15
2/23/2017 6:50:20 AM RBC Capital Markets Is Cutting Esperion Therapeutics (ESPR) Q3 17 Estimate To -1.51 From -1.28
2/23/2017 6:50:00 AM RBC Capital Markets Is Lowering Esperion Therapeutics (ESPR) Q2 17 Estimate To -1.42 From -1.12
2/23/2017 6:49:37 AM RBC Capital Markets Is Lowering Esperion Therapeutics (ESPR) Q1 17 Estimate To -1.33 From -0.97
2/23/2017 6:49:25 AM RBC Capital Markets Is Lowering Esperion Therapeutics (ESPR) Q4 16 Estimate To -1.28 From -0.81
11/4/2016 9:09:41 AM RBC Capital Markets Is Cutting Esperion Therapeutics (ESPR) 2017 Estimate To -4.52 From -3.59
11/4/2016 9:09:27 AM RBC Capital Markets Is Cutting Esperion Therapeutics (ESPR) 2016 Estimate To -2.85 From -2.84
5/5/2016 9:24:25 AM RBC Capital Markets Is Cutting Esperion Therapeutics (ESPR) 2017 Estimate To -3.43 From -3.25
5/5/2016 9:19:58 AM RBC Capital Markets Is Lowering Esperion Therapeutics (ESPR) 2016 Estimate To -2.88 From -2.73
11/6/2015 8:51:52 AM RBC Capital Markets Is Raising Esperion Therapeutics (ESPR) 4Q15 Estimate To -0.58 From -0.69